TT-01025 is under clinical development by LG Chem Life Sciences Innovation Center and currently in Phase I for Metabolic Dysfunction-Associated Steatohepatitis (MASH).
The Hon Rodney Charles is a friend. My disagreement with his Facebook post of January 3 should be construed as a difference of opinion on a matter he raised.Charles wrote ...